A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF EVEROLIMUS, AN ORAL MTOR INHIBITOR, IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION Статья Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z. EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD. Том 47. 2011.
INFLAMMATION RESEARCH Сборник материалов конференции 40th Annual Meeting of the European-Histamine-Research-Society. SPRINGER BASEL AG.